STOCK OPTION AGREEMENT UNDER THE ATOSSA THERAPEUTICS, INC. 2020 STOCK INCENTIVE PLAN (Subject to Shareholder approval May 15, 2020)Stock Option Agreement • April 13th, 2020 • Atossa Therapeutics, Inc. • Pharmaceutical preparations
Pursuant to the Atossa Therapeutics, Inc. 2020 Stock Incentive Plan (the “Plan”), Atossa Therapeutics, Inc. (the “Company”) hereby grants to the Optionee named above an option (the “Stock Option”) to purchase on or prior to the Expiration Date specified above all or part of the number of shares of Common Stock, par value $0.18 per share (the “Stock”), of the Company specified above at the Option Exercise Price per Share specified above subject to the terms and conditions set forth herein and in the Plan; provided, however, that if the Grant Date is prior to stockholder approval then the Stock Option is subject to and conditioned upon stockholder approval on May 15, 2020 of the Plan.
